Intarcia Therapeutics

Pathological lying is defined as telling lies to the point they are persistent, extremely exaggerated and often told without a discernible reward. Psychiatrists have not given pathological lying the title of a true mental disorder as of yet, though this behavior is suggestive of a mental disturbance. Pathological liars are often motivated by low self-esteem to spin a web of lies that make them appear more important or to garner attention from others. Confronting someone you know regarding their pathological lying is a difficult proposition and should be carefully planned.

Step 1
Learn all you can about pathological lying and what motivates the behavior to better understand the person. This will allow you to confront him in an educated manner when you are ready.

Step 2
Discern whether the person is actually a pathological liar. Many people fib often, but a pathological liar is one who lies most of the time. Pathological liars, for example, create whole histories that are fiction rather than just telling a little white lie to get out of a social engagement.

Step 3
Listen to the individual closely. Stop him when he says something bizarre and ask him how it can be true. You can also catch him in small contradictions, which you can question. Do not, however, try to confront him with the “big” stuff at this point.

Step 4
Reassure your friend that he does not have to be anything he’s not to impress you. Let him know you value him just as he is. If you really don’t like the person due to the lying then stay away from him.

Step 5
Decide whether the relationship with the pathological liar is too toxic for you to handle. Pathological liars can overcome the propensity to lie, but it takes willingness and, usually, therapy, so to be a friend you need to be there for the long run. Often though, the person does not want help, at which point you need to make a clean break to keep from being hurt.

Step 6
Talk to your friend about getting professional help once you have proven to him that you have his best interests at heart. You will likely have to confront him with “proof” of his lies to get him to admit he has a problem (and even then he may not).

Step 7
Make your friend accountable for what he says, you may need to contact authorities to ask for help. Remember you will also be held accountable if people are injured or put in danger due to his lies. Be true to yourself and make sure you are not repeating stories from the pathological liar. Often they seek others to repeat their tales as a way to make them sound plausible.

Warnings

• Many liars perpetuate scams on sympathetic individuals. If you have an inkling that something is not quite right about a person, that their “stories” seem contrived or bizarre, you may be dealing with a pathological liar and need to take measures to protect yourself.

 

Approval by March 1, 2018

 

No way troll for Kurt. They did not post CRL and heard that they need to develop, qualify and validate whole new process - typical 12 to 18 months. Best part is when FDA stumbled upon and made observations about the joke sterile environment.

 

Pathetic as regurgitating OLD NEWS from the triasl done 2004-2011!

The perennial 20+ yr old start-up started shop as Biomedicines (they changed the name to Intarcia in 2004) and focus included 2 FAILED trials using ITCA to deliver omega interferon back 13+ years ago!

Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
Purpose

https://www.clinicaltrials.gov/ct2/show/NCT00519792?term=intarcia+hepatitis&rank=1

Purpose
Omega DUROS® is an implantable drug delivery system designed to deliver omega interferon subcutaneously at a constant rate for 90 days.

This study is being performed to evaluate the safety and antiviral effects of omega interferon delivered by the Omega DUROS® device in combination with ribavirin in subjects with chronic Hepatitis C genotype 1.


Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

https://www.clinicaltrials.gov/ct2/show/NCT00097045?term=intarcia+hepatitis&rank=2

Purpose
This study is designed to compare the safety, tolerability and antiviral effects of omega interferon administered alone to omega interferon administered with ribavirin in the treatment of subjects with chronic Hepatitis C virus (HCV) infection.

 

Kurt is an expert in HCV ask Vertex ...and BioLuxe... and Achillion... a real expert in every failed HCV program

 

So far, we haven’t been able to find a copy of the promotion materials used in fund raising for Intarcia, and a spokeswoman for the U.S. Attorney’s office for the District of Massachusetts told us the promotional materials are of high interest. We’d still like to see them. If you have a copy, please email ryan.reilly@huffpost.com or contact us on Signal at 202-527-9261.

 

Good luck getting the copies of slick PowerPoint presentations filled with wild ass assumptions presented as semi-facts to the mostly gullible Asian investors. Be aware that many versions exist so focus on the promo materials used since after 2014 targeted for the hybrid joke convertible debt issued for the meager 1.5% of future revenue (LOL as approval got delayed by months due to CRL received in late Sept) and soon to be Chinese and Korean bagholders (since no non-Asian VCs or funds would give additional $$$ to Intarcia but demanded to get their $$$ back - case in point when couple of VCs sold their stakes to Chinese investors in early 2015).

And the only way to get them promo materials are subpoena but suspect most "evidences" got wiped out clean so contact the hopping mad bagholders.

 

Uh oh, is Kurt being investigated by DoJ for fraud? They do go after stock shysters:

https://www.bostonglobe.com/business/2014/06/27/district-court-boston-indicts-financial-adviser-wire-fraud-charges/hZRn53qMF1M3R3A1Kyi7NI/amp.html


Court indicts Pa. financial adviser on wire fraud charges
By Chris Reidy Globe Staff June 27, 2014

The US District Court in Boston indicted a financial adviser affiliated with a Massachusetts-based broker dealer on charges that she defrauded investors of more than $2.5 million, the US attorney’s office and the FBI said.

Patricia S. Miller, 67, of Pennsylvania, was charged with five counts of wire fraud, the US attorney’s office and the FBI said in a press release.

According to the release, Miller persuaded about 20 clients to put money into her investment clubs. The money was supposed to be placed in fixed-income notes and other investments. But instead of investing the money, “she misappropriated client funds for her own use,” the release said.

Attempts to reach Miller’s attorney were not immediately successful.

If convicted, Miller faces a maximum sentence for each count of wire fraud of 20 years in prison, three years of supervised release, and a $250,000 fine.

 

Plot thickens as DoJ's scrutiny may have resulted in Kurt's right hand money man Owen "resign to pursue his dream as start-up biotech CEO" in mid Sept. Owen was probably fired by BoD and boardroom revolt with 3 of 7 board members leaving the board (more like recluse themselves from the frauds) certainly does not bode well. Add to this the CRL woes in late Sept and this puppy is going down fast.

PS - the press release about ITCA Omerga Interferon PR last week was pathetic joke on par as fraud. Interim Ph 2 study on clinical studies aborted in 2007 with NO study results has awoken from the grave 10 yrs later?

 

My manager told me layoffs by Thanksgiving so everyone is out the door before the New Year. It is totally unfair to be the viticm of a problem that we did't make. How can it be that nobody cares after all we have done.

 

I'll call BS n that one. I sit in with some Hayweird ULT and it's all about saving a sinking ship right now, not jumping off it. Besides, there is still money to burn through before "everyone is out the door"

 

How deeply sunk ? We are told less than six month delay - but never really hear the Hayweird story.

 

I think there will be some layoff but not shut the whole Hayweird plant impacting mostly low level production and QC workers. That said they are better off shit can the whole plant expanded by knee jerk reaction hodge podge manner and build a new cleanrooms inside the warehouse structure.

Indeed the ULT rats whose hairs are on fire are busy rearranging the deck chairs while playing fiddle to assuage the freaked out workforce actively looking for jobs. I give it another 3-6 months till more marketable ULT members leave in droves jumping the ship on to the rubber dinghies while the guilty as hell old ULT members shoot arrows to deflate the rubber dinghies.

And in a year it will be all over or sooner if the rumour is true bout DoJ Boston is investigating...

 

6 month is pie in the sky fantasy KG has been spewing to the pissed off investors. It's a way for him to fend off the anger and absolute angst and buy more time.

Reality though is more like 18 months as this is the average time for the most companies to get out the CRL holes. However, Hayweird woes are deep and wide as FDA has loosened up to approve more drugs especially if there are no alternatives but Type II diabetes market is full of proven and CHEAP drugs.

As for Hayweird story - they need a new plant at one extreme and new processes at the other extreme which means new equip, process development and qualification to be followed by validation - not for faint of heart and they will madly rush and cut corners (the cornerstone of what's wrong in Hayweird) into create a fix without understanding the processes and will fail validations again. They say we learn history so as not to repeat it.

 

Agreed. 6 months is probably to address the CRL, then resubmit. Tack on 10-12 months for the review cycle and pray it gets approved (which I have doubts). So best case, and I mean absolute perfect, is approval in Q1 2019. But I'll guess their CRL response will be as crappy as the NDA submission.
Also, like you mentioned new processes, equipment, and facilities. How can they qualify any of that when there isn't even a Validation group? Lol

 

Excellent points. Heard that our jobs are safe till Q1 2018. I think they are hoping that there is enough attrition to avoid ugly layoffs. Besides they have to follow WARN rule in California by giving advanced 60-day notice of layoff. NDA was rushed with Boston HQ people breathing down our necks and we were relieved when FDA accepted it. Management is still under delusion or are damn good actors talking up that we get approved in 6 months.

 

Trolls spewing longer delays. Sales force will be on board in 1Q 2018. First prescription March 15, 2018. Forecast 2018 Sales $365 Million.

 

Hopium at best. Do ya really think you will find talents to peddle this pricey whatchamacallit by Q1 after the 3 ring circus recruiting fanfare?

 

Go Away Troll. People are beggin to join our sales force and disrupt the diabetes market. We will be fully staffed and on the path to blockbuster status by April 1 2018. Intarcia plans to announce our sales success and celebrate our Investors on that day.

 

Oh yeah definite launch within 6 months - this FDA shit is easy